Early on a beautiful spring morning in the nation’s capital, a group of Georgetown University undergraduates gathered on the corner of First Street and Constitution Avenue, far from their textbooks and thoughts of their looming final exams. Their unusual study break? A day of meetings with congressional offices to advocate against cuts to critical U.S. government funding for global health.

Past Work

For more than a decade, the Sabin PDP collaborated with partners from across the globe to develop new, low-cost vaccines that have little commercial market for diseases that primarily impact the world's poorest populations, including humanhookworm, schistosomiasis, onchocerciasis, SARS and Chagas disease. Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development continue this research as of May 2017.

What the poor suffer from most happens in developed countries

While rarely talked about, Neglected Tropical Diseases are the most widespread ailment among the world's poorest of the poor – yet also ironically the most prevalent in top global economies, experts say.

Neglected Tropical Diseases (NTDs) are “the most important diseases you've never heard of. These are the most common afflictions of the world's poor,” Peter Hotez, MD, PhD, told CNA Nov. 11.

Catholic News Agency
River blindness, also known as onchocerciasis, has endangered Guatemalan’s eyesight since at least 1915. Last month, however, just over a century after the country’s first onchocerciasis diagnosis, the World Health Organization (WHO) declared the disease officially eliminated from the Land of Eternal Spring.

Last year, the leaders of some of the wealthiest nations pledged help control and eliminate the most common neglected tropical diseases (NTDs) by 2020.

Photo: Sabin CEO Michael W. Marine, Ambassador (Ret.), with Former President of Ghana, John Kufuor

Sabin’s President, Dr. Peter Hotez, received the 2015 RESULTS Seeds of Hope Award on Sunday in Houston, Texas. Each year, this award honors a person in the Houston community who has made extraordinary contributions towards improving health, education or microfinance — the three pillars of RESULTS advocacy. This year’s award honored advances in Child and Maternal Health.
During the month of October, END7 student supporters are celebrating NTD Success Stories — spreading the exciting news that many countries around the world have already made incredible progress towards the control and elimination of some NTDs. In recent weeks, there have been many new successes to celebrate.

New Partnership with India Aims to Build Vaccine Manufacturing Network for Hookworm, Other Diseases

WASHINGTON, D.C., BANGALORE, AMSTERDAM — October 14, 2015 — The Amsterdam Institute for Global Health and Development (AIGHD) and Sabin Vaccine Institute Product Development Partnership (Sabin PDP) today announced a new research and innovation partnership with the Association of Biotechnology Led Enterprises (ABLE) of India on vaccine development for hookworm and other neglected tropical diseases (NTDs). The European Union, through its EuropeAid program, recently awarded a five-year grant of €333,000 to AIGHD to establish this EU-India partnership.

Pages

Subscribe to RSS - NTDs